Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorescence Imaging for SLN Biopsy in Breast Cancer and Melanoma
NCT02316795Phase 1Completed
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in breast cancer and melanoma, sponsored by Washington University School of Medicine. Primary endpoint: Sentinel Lymph Node Identification at 1.5 hours. Started Feb 2014; status: completed.
02
Conditions
breast cancermelanoma
Beyond the preview
Go deeper on NCT02316795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02316795.